BAK three-lens brief
Evidence-based stock research on BAK. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price up 7.11% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price up 7.11% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 10.5pp over 30 days.
- Analyst mean target $3.25 — 54% above current (4 analysts).
- Negative free cash flow last quarterly (-$7.60B).
BAK closed at $2.11 (+7.11%) as of 2026-09-11. Market cap: $476.76M. Price is below the 50-day MA and below the 200-day MA. Positives: price up 7.11% in the last session — a material single-day move.; analyst mean target $3.25 — 54% above current (4 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 10.5pp over 30 days.. Last quarter: Revenue $21.71B, net income $3.33B, free cash flow -$7.60B.
Why three lenses on BAK, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BAKacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BAK" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BAK brief"></iframe>